• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

AstraZeneca and Daiichi Sankyo’s Enhertu shows promise in breast cancer trial

cafead

Administrator
Staff member
  • cafead   Apr 29, 2024 at 11:22: AM
via AstraZeneca and Daiichi Sankyo have announced that their therapy Enhertu has shown a statistically and clinically meaningful progression-free survival (PFS) improvement in patients with HR-positive, HER2-low metastatic breast cancer.

article source
 

<